These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 8734736

  • 1. Radiotherapy for stage T3b transitional cell carcinoma of the bladder.
    Pollack A, Zagars GZ.
    Semin Urol Oncol; 1996 May; 14(2):86-95. PubMed ID: 8734736
    [Abstract] [Full Text] [Related]

  • 2. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
    Cole CJ, Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC.
    Int J Radiat Oncol Biol Phys; 1995 May 15; 32(2):331-40. PubMed ID: 7751174
    [Abstract] [Full Text] [Related]

  • 3. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
    Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnell TJ.
    Clin Cancer Res; 1997 Oct 15; 3(10):1823-9. PubMed ID: 9815569
    [Abstract] [Full Text] [Related]

  • 4. [Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and metastasis].
    Escudero Barrilero A, Allona A, Berenguer A, Burgos J, Castañeda A, Negrin A, Tellez M.
    Actas Urol Esp; 1991 Oct 15; 15(2):124-38. PubMed ID: 1807106
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW, Bristow RG, Milosevic MF, Yi QL, Jewett MA, Warde PR, Catton CN, McLean M, Moore M, Tannock IF, Gospodarowicz MK.
    Urol Oncol; 2007 Oct 15; 25(4):303-9. PubMed ID: 17628296
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec 15; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 7. Radical cystectomy for stage T3b bladder cancer.
    Hall CM, Dinney CP.
    Semin Urol Oncol; 1996 May 15; 14(2):73-80. PubMed ID: 8734734
    [Abstract] [Full Text] [Related]

  • 8. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 May 15; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A, Fernández Fernández E, Jiménez Cidre M, Maganto Pavón E, Mayayo Dehesa T, Rodríguez Rodríguez R, Galvis San Juan F, Burgos Revilla FJ.
    Arch Esp Urol; 1996 May 15; 49(4):349-64. PubMed ID: 8754191
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The relationship of local control to distant metastasis in muscle invasive bladder cancer.
    Pollack A, Zagars GK, Cole CJ, Dinney CP, Swanson DA, Grossman HB.
    J Urol; 1995 Dec 15; 154(6):2059-63; discussion 2063-4. PubMed ID: 7500458
    [Abstract] [Full Text] [Related]

  • 12. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X, Condom E, Vigués F, Castellsagué X, Figueras A, Muñoz J, Solá J, Soler T, Capellà G, Germà JR.
    Cancer; 2004 May 01; 100(9):1859-67. PubMed ID: 15112266
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug 01; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 15. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B, Félix-Faure C, Davin JL, Choquenet C, Alfonsi M, Reboul F.
    Cancer Radiother; 1998 Apr 01; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [Abstract] [Full Text] [Related]

  • 16. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
    Chauvet B, Brewer Y, Félix-Faure C, Davin JL, Choquenet C, Reboul F.
    J Urol; 1996 Oct 01; 156(4):1258-62. PubMed ID: 8808849
    [Abstract] [Full Text] [Related]

  • 17. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T, Tomic R, Ljungberg B.
    Scand J Urol Nephrol; 2009 Oct 01; 43(4):293-9. PubMed ID: 19363744
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bladder preservation and continent urinary diversion in T3b transitional cell carcinoma of the bladder.
    Cespedes RD, McGuire EJ, Donat SM, Babaian RJ.
    Semin Urol Oncol; 1996 May 01; 14(2):103-11. PubMed ID: 8734738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.